An overview on Gastric Carcinoma with its recent statistical ranges throughout the world

Authors

  • Venkatesh Goli Department of Pharmaceutical chemistry, Sir CRR college of pharmaceutical sciences, GNT Road, Shanthi Nagar, Eluru, India
  • Om Sai Prakash Lanka Department of Pharmaceutical chemistry, Sir CRR college of pharmaceutical sciences, GNT Road, Shanthi Nagar, Eluru, India
  • J.R. Tulasi Department of Pharmaceutical chemistry, Sir CRR college of pharmaceutical sciences, GNT Road, Shanthi Nagar, Eluru, India

DOI:

https://doi.org/10.21276/IJRDPL.2278-%200238.2018.7(6).3172-3184

Keywords:

Gastric cancer, stomach cancer, Stages of cancer, TNM classification, Globocan 2018

Abstract

Gastric cancer is the Fifth most common cancer and third most cause of cancer-related deaths in the world. The Decreasing number from the last two decades is the effect of the Healthy lifestyle, and Helicobacter pylori eradication, The review article pronounces the importance of mass screening and early detection in high risk population and summarizes the most important aspects of gastric cancers, which include epidemiology, risk factors, classification, tumor markers, diagnosis, prevention, ,treatment strategies for different stages of cancer and their five year survival rate. It also emphasizes global updated statistics of stomach cancer incidence, mortality rate and highly prevalent areas of this cancer to provide basic details to the researcher for identifying the need of developing more screening programs in high risk population and develop new treatments to improve the quality of life and survival rate in these people.

Downloads

Download data is not yet available.

References

Gunderson LL, Donohue JH, Alberts SR, Ashman JB, Jaroszewski DE. Cancer of the Stomach and Gastroesophageal Junction. In: Niederhuber, JE, Armitage, JO, Doroshow, JH, Kastan, MB, Tepper, JE, eds. In Abeloff's Clinical Oncology. 5th ed. Philadelphia, Pa: Elsevier; 2014:1240-12

National Cancer Institute. Physician Data Query (PDQ). Gastric Cancer Treatment. 2/2/2017. Accessed at: www.cancer.gov/cancertopics/pdq/treatment/gastric/HealthProfessional on November 20, 2017. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Gastric Cancer. v.3.2017. Accessed at www.nccn.org/professionals/physician_gls/pdf/gastric.pdf on November 20, 2017. Last Medical Review: December 1, 2017 Last Revised: December 15, 2017

Gunderson LL, Donohue JH, Alberts SR, Ashman JB, Jaroszewski DE. Cancer of the Stomach and Gastroesophageal Junction. In: Niederhuber, JE,

Armitage, JO, Doroshow, JH, Kastan, MB, Tepper, JE, eds. In Abeloff's Clinical Oncology. 5th ed. Philadelphia, Pa: Elsevier; 2014:1240-12

Gunderson LL, Donohue JH, Alberts SR, Ashman JB, Jaroszewski DE. Cancer of the Stomach and Gastroesophageal Junction. In: Niederhuber, JE, Armitage, JO, Doroshow, JH, Kastan, MB, Tepper, JE, eds. In Abeloff's Clinical Oncology. 5th ed. Philadelphia, Pa: Elsevier; 2014:1240-1270.

National Cancer Institute. Physician Data Query (PDQ). Gastric Cancer Screening.3/10/2017. Accessed at https://www.cancer.gov/types/stomach/hp/stomach-screening-pdq on November 27, 2017. Last Medical Review: December 1, 2017 Last Revised: December 14, 2017.

Balakrishnan M, George R, Sharma A, Graham DY. Changing trends in stomach cancer throughout the world. Curr Gastroenterol Reg. 2017;19:36.

Food and Drug Administration. FDA grants accelerated approval to pembrolizumab for advanced gastric cancer. 2017. Accessed at https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm577093.htm

on November 20, 2017.

Ford AC, Forman D, Hunt R, Yuan Y, Moayyedi P. Helicobacter pylori eradication for the prevention of gastric neoplasia. Cochrane Database of Systematic Reviews. 2015;7. Art. No.: CD005583.

Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: An open-label, randomised controlled trial. Lancet. 2008;372:392-397.

Koizumi W, Akiya T, HaraT et al. S-1 plus cisplatin versus S-1 alone for first line treatment of advanced gastric cancer (SPIRITS trial): A phase III trial. Lancet Oncol.2008;9:215-221.

LKS Biopharma. FDA grants apatinib orphan drug designation for treatment of gastric cancer. 2017. Accessed at http://lskbiopharma.com/the-us-fda-grants-apatinib-orphan-drug-designation-for-treatment-of-gastric-cancer/ on November 20, 2017.

National Cancer Institute. Physician Data Query (PDQ). Gastric Cancer Treatment. 2/2/2017. Accessed at: www.cancer.gov/cancertopics/pdq/treatment/gastric/HealthProfessional on November 20, 2017.

Shah M. Future directions in improving outcomes for patients with gastric and esophageal cancer. Hem Onc Clinics North America. 2017;31:545.

Shida A, Mitsumori N, Nimura H, Takano Y, Iwasaki T, Fujisaki M, Takahashi N, Yanaga K. Prediction of lymph node metastasis and sentinel node navigation surgery for patients with early-stage gastric cancer. World J Gastroenterol. 2016;22:7431-9.

Tian W, Zhao Y, Liu S, Li X. Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer. Eur J Cancer Prev. 2010;19:288-298.

Wagner AD, Syn NLX, Moehler M, Grothe W, Yong WP, Tai BC, Ho J, Unverzagt S. Chemotherapy for advanced gastric cancer. Cochrane Database of Systematic Reviews. 2017;8. Art. No.: CD004064.

Walker R, Poleszczuk J, Mejia J, Lee JK, Pimiento JM, Malafa M, Giuliano AR, Enderling H, Coppola D. Toward early detection of Helicobacter pylori-associated gastric cancer. Gastric Cancer. 2017. Last Medical Review: December 1, 2017 Last Revised: December 14, 2017.

Avital I, Stojadinovic A, Pisters PWT, Kelsen DP, Willett CG. Cancer of the stomach, In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2015.

Capelle LG, de Vries AC, Looman CW, et al. Gastric MALT lymphoma: Epidemiology and high adenocarcinoma risk in a nation-wide study. Eur J Cancer. 2008;44:2470-2476.

Chun N, Ford JM. Genetic testing in stomach cancer, In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2015.

Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomized controlled trial. Lancet. 2010;376:687?697.

Fuchs CS, Tomasek J, Yong CJ, et al. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet. 2014 Jan 4;383(9911):31-9. Epub 2013 Oct 3.

Muro K, Boku N, Yamada Y et al. Multicenter phase II study of RAD001 for previously treated metastatic gastric cancer:

Preliminary results. J Clin Oncol. 2008;26 (May 20 suppl; abstr 4541).

National Cancer Institute. Physician Data Query (PDQ). Gastric Cancer Treatment. 2/2/2017. Accessed at: www.cancer.gov/cancertopics/pdq/treatment/gastric/HealthProfessional on November 20, 2017.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Gastric Cancer. v.3.2017. Accessed at www.nccn.org/professionals/physician_gls/pdf/gastric.pdf on November 20, 2017.

Song H, Zhu J, Lu D. Molecular-targeted first-line therapy for advanced gastric cancer. Cochrane Database of Systematic Reviews. 2016;7. Art. No.: CD011461. DOI: 10.1002/14651858.CD011461.pub2.

Wong H, Yau T. Targeted therapy in the management of advanced gastric cancer: Are we making progress in the era of personalized medicine? Oncologist. 2012;17:346-358. Last Medical Review: December 1, 2017 Last Revised: December 15, 2017

PDQ® Colorectal Cancer Screening summary.

PDQ® Screening and Prevention Editorial Board. PDQ Stomach (Gastric) Cancer Screening. Bethesda, MD: National Cancer Institute. Updated . Available at: https://www.cancer.gov/types/stomach/patient/stomach-screening-pdq. Accessed . [PMID: 26389488]

Ferlay J, soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN2012. Int J Cancer 2015;136:E359-86.

How to cite this article:

Venkatesh, Sharma P, Tulasi J.R. An overview on Gastric Carcinoma with its recent statistical ranges throughout the world. Int. J. Res. Dev. Pharm. L. Sci. 2018; 7(6): 3172-3184. doi: 10.13040/IJRDPL.2278-0238.7(6).3172-3184

This Journal is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.

Published

2018-12-15

How to Cite

Goli, V. ., Lanka, O. S. P. ., & Tulasi, . J. (2018). An overview on Gastric Carcinoma with its recent statistical ranges throughout the world. International Journal of Research and Development in Pharmacy & Life Sciences, 7(6), 3172 - 3184. https://doi.org/10.21276/IJRDPL.2278- 0238.2018.7(6).3172-3184